Medicine

Niacin, food items intake as well as heart impacts

.Attributes Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, fo...

Opportunities and obstacles for patient-reported outcome analysis in multimorbidity analysis as well as method

.Completing rate of interests.S.E.H. receives financing from the National Institute of Health and Ca...

Hibernation science used to handle being overweight as well as change metabolic process

.Attributes Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy compre...

CAR- T and cell genetics treatments are also expensive

.Mother Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-o...

The WHO genomics program of help nondiscriminatory execution of human genomics for international health

.The magazine of the first draft of the human genome sequence in 20011 was actually observed due to ...

A time-stratified, case\u00e2 $ \"crossover research of heat visibility and perinatal mortality from 16 health centers in sub-Saharan Africa

.Among 138,015 hospital-based individual births in four sub-Saharan African nations, our team monito...

Advancing international antibiotic research, development and also accessibility #.\n\nMurray, C. J. L. et cetera. Worldwide burden of bacterial antimicrobial protection in 2019: a methodical study. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. Towards certain commitments and also activity in the reaction to antimicrobial protection. Global Frontrunners Group on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Globe Wellness Association. WHO publishes listing of micro-organisms for which new prescription antibiotics are urgently needed. Planet Wellness Institution https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). World Health Institution. WHO microbial concern pathogens listing, 2024: bacterial pathogens of hygienics significance to direct research, growth and tactics to avoid and also control antimicrobial resistance. Planet Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative entrance. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nWorld Wellness Association. 2023 anti-bacterial representatives in professional and preclinical advancement: a summary and also study. Planet Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Review. May 19, 2016 \u00e2 $\" Handling drug-resistant contaminations globally: last file and also suggestions. Review on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB results: files and also rundown. Steer AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall: a call for collective action on anti-biotics trial and error. Boston ma Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Concise 51: How can the EU assistance sustainable development and access to helpful prescription antibiotics? plan alternatives for existing and brand new medicines. European Observatory on Health Systems and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic usage and also resistance\u00e2 $\" showing the noticeable. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Association. 2021 Mindful category. That accessibility, watch, reserve, classification of prescription antibiotics for assessment as well as monitoring of use. Globe Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Facility for Disease Prevention and also Management. Antimicrobial protection targets: just how can we reach all of them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Health And Wellness Association. Shortage of development readied to weaken antibiotic performance and also health and wellness increases. Planet Health and wellness Association https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. Exactly how antimicrobial resistance is connected to temperature improvement: a guide of pair of linked international difficulties. Int. J. Environ. Res. Public Health 20, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial diseases: we require important action and also assets that concentrate on the weakest web link. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health And Wellness Company. Booster shot coverage. Globe Wellness Organization https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection deterrence and control in low-resource environments: the need for the neighborhood, the contextual as well as the practical. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Challenges of carrying out antimicrobial stewardship resources in reduced to center income nations (LMICs). Infect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A short past history of the antibiotic period: courses discovered as well as challenges for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K. et cetera. Individual access in 14 high-income countries to new antibacterials permitted by the United States Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals as well as Medical Gadget Firm, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health And Wellness Association. 2021 antibacterial brokers in medical as well as preclinical growth: a summary as well as evaluation. Globe Health Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the economics have to assist the scientific research. Attributes 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of innovation in anti-bacterial therapies. Biotechnology Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Analyzing medical professional application of next-generation anti-biotics against immune Gram-negative diseases in U.S. hospitals: a retrospective accomplice research study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The condition of technology in anti-bacterial therapies. Biotechnology Development Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A step-by-step testimonial as well as crucial assessment of reward strategies for exploration as well as advancement of novel anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth And Wellness Emergency Situation Preparedness and Response Authority. R &amp d of clinical countermeasures. International Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Payment. Pre-draft plan for an International collaboration under Horizon Europe One Wellness Antimicrobial Resistance. International Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). International Prescription Antibiotic Trial And Error Collaboration. Entasis Rehabs and also the Worldwide Prescription Antibiotic Study &amp Advancement Relationship to establish a brand new treatment for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of sector- and also non-industry-sponsored clinical trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Wellness Organization. Amount of clinical trial registrations through area, condition, stage of advancement, grow older and also sexual activity of test individuals (1999\u00e2 $ \"2022). World Wellness Association https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Prescription Antibiotic Experimentation Alliance. NeoSept1: a research to identify the position of existing as well as brand-new anti-biotics combinations to handle newborn babies who are in health center along with serious sepsis. ISRCTN computer system registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Organization of Canada. Authorities of Canada creates vital expenditure to eliminate antimicrobial resistance (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Prescription Antibiotic R &amp D Partnership. Asia federal government financing assists GARDP\u00e2 $ s efforts to resist antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Structure. Novo Nordisk Structure partners with CARB-X to combat drug-resistant diseases. novo nordisk structure https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Wellness and also Digital Manager Company. Research study on carrying AMR health care countermeasures to the marketplace. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Predicting the ideal dimension of global pull motivations for anti-bacterial medications. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entrance benefit for the growth of new prescription antibiotics. Harvard Kennedy College https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Industry incentives and antibiotic resistance: an overview to the antibiotic sensitivity bonus offer. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An enthusiastic USG advanced dedication for subscription-based investing in of novel antimicrobials and also its own assumed roi. Facility for Global Growth https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 expenditures in brand-new antibiotics would repay \u00e2 $\" for everybody. Workplace of Wellness Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up fight against lethal infections observing effective world-first fly. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Commission. Reform of the EU pharmaceutical legalisation. International Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Reimbursement models to tackle market failings for antimicrobials: methods absorbed France, Germany, Sweden, the United Kingdom, as well as the USA. Health Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers and Affiliations. Coming from protection to resilience: what could the potential antibiotic pipe seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Center &amp Planet Health Organization. Incentivising the development of brand new antibacterial therapies: 2023 progress report due to the Worldwide AMR R&ampD Hub and also WHO. International AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Vocalist, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK membership version for prescription antibiotics considered effective? Lancet Germ 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" novel stimulations for the advancement and keeping the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, as well as national causes of little one death in 2000\u00e2 $ \"13, with forecasts to inform post-2015 top priorities: an improved organized analysis. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Anti-bacterial drug lacks coming from 2001 to 2013: effects for professional practice. Clin. Contaminate. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et cetera. The French coverage system for medication shortages: description and trends coming from 2012 to 2018: an empirical retrospective research. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et al. Evaluation of WHO antibiotic consumption as well as get access to intendeds in 76 countries, 2000\u00e2 $ \"15: a review of pharmaceutical sales records. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Combating the fakes: tackling low-grade and falsified medications. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving much easier to get anti-biotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Society for Research Laboratory Medication. Plan short and infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic intake for human usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Med. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial intake: evaluation of central storehouses products to in-patient treatment wellness amenities from 2017 to 2019 in Uganda. Trop. Medication. Corrupt. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Variants in the usage of antimicrobial medicines in the European region, 2014\u00e2 $ \"2018: seekings and also effects from ESAC-Net and also That Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et al. Medicine lack: reasons, effect, and minimization methods. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Individual accessibility in 14 high-income nations to new antibacterials permitted due to the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals as well as Medical Gadget Agency, or Health Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et al. Lost antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness innovation for worldwide health. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Business Collaboration. The 2023 AMR Sector Partnership development poll: manufacturing as well as the setting. amr Industry Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can clinical products be developed on a charitable basis? Exploring item development partnerships for forgotten illness. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et al. Restart biomedical R&ampD in the international public rate of interest. Nature 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Disease Control and also Avoidance. Africa CDC heads daring relocate to protect Africa\u00e2 $ s wellness future through generating a fifty billion dollar clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Bargaining public-health copyright licensing agreements to raise accessibility to health modern technologies: an insider\u00e2 $ s story. BMJ Chunk. Health 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New business designs for r &amp d along with cost demands are actually required to achieve decent pricing of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Accelerator. Stewardship and also accessibility. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Global Prescription Antibiotic R &amp D Collaboration. Shinogi, GARDP and CHAI announce spots license and cooperation agreements to alleviate microbial infections by increasing access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Alliance. Leaving the laboratory: tracking the decrease in AMR R&ampD professionals. amr Sector Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 contact us to activity on antimicrobial resistance. G7G20 Documentations Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). Global Coalition on Growing Old &amp Transmittable Diseases Culture of United States. 2024 AMR preparedness index report card. Assessing government activity on AMR policy. International Coalition on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items as well as Horticulture Company of the United Nations, United Nations Setting Programme, Planet Health And Wellness Organization &amp. Planet Organization for Pet Wellness. Global data source for tracking antimicrobial resistance (AMR): country self-assessment survey (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the wides...

Integrating liver endpoints in scientific trials of cardio and kidney condition

.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpo...

FALSE:: INACCURACY: UNSUPPORTED ENCODING...

Artificial intelligence helped screening for cardiomyopathies in an obstetric population: a practical randomized professional test

.Trial design and oversightThe Assessment for PEripartum Cardiomyopathies with Artificial Intelligen...